Mostrar el registro sencillo del ítem

dc.rights.licenseLicencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacionalspa
dc.contributor.authorDíaz-Pérez, Anderson
dc.contributor.authorRoldán Menco, Consuelo
dc.contributor.authorBarrios Puerta, Zorayda
dc.contributor.authorBadillo-Viloria, María
dc.contributor.authorNavarro-Quiroz, Elkin
dc.contributor.authorYañez Torregroza, Zuleima
dc.contributor.authorMendoza Cataño, Carmenza Leonor
dc.description.abstractObjective: To determine the prevalence of metabolic syndrome (SM) according to Adult Treatment Panel III ATPIII and its relation with uric acid concentration and C-reactive protein, in people aged from 45 to 60 years old from the Getsemaní neighborhood of Cartagena city, Colombia. Materials and Methods: Type of study: Observational, Descriptive-Correlation. Population of 802 inhabitants from the Getsemaní neighborhood of Cartagena city. We analyzed 302 inhabitants from a random sample with 95% confidence level and 5% of error level. The ATP III diagnostic criteria were applied, the applied instrument had basic data about the general context (social, demographic, economic aspects, family history, work activity and its physical characteristics: weight, waist circumference, blood pressure, calculation of BMI), as well diagnostic tests as: glycaemia, total cholesterol, triglycerides, HDLc, LDLc, uric acid, ultrasensitive C-reactive protein. Results: The population susceptible to metabolic syndrome presented a prevalence of 18%. The most prevalent metabolic syndrome factor was abdominal obesity with 85%, followed by an increase in triglycerides by 76%. Conclusion: When applying the ATP III criteria, the prevalence of metabolic syndrome was considered high. There was no significant association of C-reactive protein values with the possibility of developing metabolic syndrome in both men and women, but uric acid results were found to be correlated in the group of women susceptible to MS with a p = 0.0022.eng
dc.publisherCanadian Center of Science and Educationeng
dc.sourceGlobal Journal of Health Scienceeng
dc.sourceVol. 10, No. 4 (2018)spa
dc.subjectUric acideng
dc.subjectRisk factorseng
dc.titleBiochemical Markers Present in a Population Susceptible to Suffering From Metabolic Syndromeeng
dcterms.referencesAguilar, M., Bhuket, T., Torres, S., Liu, B., & Wong, R. J. (2015). Prevalence of the metabolic syndrome in the United States, 2003-2012. Jama, 313(19), 1973-1974.
dcterms.referencesArias, C., Valdivieso, R., Núñez, M., Inga, M., Sosa, F., & Acosta, O. (2011). Evaluación del índice de masa corporal y su relación con la hiperglucemia en pacientes diabéticos tipo 2, en Lima Metropolitana, durante el año 2011. In Anales de la Facultad de Medicina, 73, 48.
dcterms.referencesAssociation, A. D. (2015). Diagnosis and classification of diabetes mellitus. Diabetes Care, 37(Supplement 1), S81-S90.
dcterms.referencesBallantyne, C. M., Hoogeveen, R. C., Bang, H., Coresh, J., Folsom, A. R., Chambless, L. E., … Boerwinkle, E. (2005). Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Archives of Internal Medicine, 165(21), 2479-2484.
dcterms.referencesBell Castillo, J., George Carrión, W., García Céspedes, M. E., Delgado Bell, E., Bell, G., & de Jesús, M. (2017). Identificación del síndrome metabólico en pacientes con diabetes mellitus e hipertensión arterial. MEDISAN, 21(10),
dcterms.referencesBiben, S., Orkin, S., & Bopp, C. (2016). Prevalence of Metabolic Syndrome Risk Factors in College-Aged Students. In International Journal of Exercise Science: Conference Proceedings, 9, 20.eng
dcterms.referencesBorghi, C., Rosei, E. A., Bardin, T., Dawson, J., Dominiczak, A., Kielstein, J. T., … Mancia, G. (2015). Serum uric acid and the risk of cardiovascular and renal disease. Journal of Hypertension, 33(9), 1729-1741.
dcterms.referencesCabalé Vilariño, M. B., Sánchez Serrano, D., Gutiérrez Carbonell, E., & Flores Sánchez, A. (2011). Prevalencia del síndrome metabólico en pacientes dislipidémicos con antecedentes de revascularización miocárdica. Revista Cubana de Investigaciones Biomédicas, 30(4),
dcterms.referencesCarvajal, C. C. (2017). Sindrome metabólico: Definiciones, epidemiología, etiología, componentes y tratamiento. Medicina Legal de Costa Rica, 34(1),
dcterms.referencesCastro, C., & Yaqueline, Y. (2016). Identificación de síndrome metabólico y comparación de las escalas Adult Treatment Panel III The National Cholesterol Education Program (ATP-III) y la Federación Internacional de la Diabetes (FID) en pacientes que acuden a chequeos ejecutivos en el Hospital de los Valles.
dcterms.referencesCulleton, B. F., Larson, M. G., Kannel, W. B., & Levy, D. (1999). Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Annals of Internal Medicine, 131(1), 7-13.
dcterms.referencesDíaz, M. S. (2015). Actualización 2015 del algoritmo ADA/EASD de tratamiento de la hiperglucemia. Diabetes Care, 38(1),
dcterms.referencesEsser, N., Legrand-Poels, S., Piette, J., Scheen, A. J., & Paquot, N. (2014). Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Research and Clinical Practice, 105(2), 141-150.
dcterms.referencesExpert Panel on Detection, E. (2001). Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Jama, 285(19), 2486.
dcterms.referencesFernández, A. G. (2016). Proteína c reactiva, índice de conicidad y factores de riesgo cardiovascular en pacientes con diabetes tipo 2. Universidad Complutense de
dcterms.referencesGarg, P. K., Norby, F. L., Polfus, L. M., Boerwinkle, E., Gibbs, R. A., Grove, M. L., … Hoogeveen, R. C. (2017). Lipoprotein-associated phospholipase A 2 and risk of incident peripheral arterial disease: Findings from the Atherosclerosis Risk in Communities study (ARIC). Atherosclerosis.
dcterms.referencesGiraldo, N. A. G., Perdomo, A. M. Z., Aristizábal, T. S. T., & Restrepo, A. E. (2017). Síndrome metabólico en un grupo de adultos mayores no institucionalizados según criterios de organismos internacionales. Perspectivas En Nutrición Humana, 18(1), 25-35.
dcterms.referencesHan, T. S., Sattar, N., Williams, K., Gonzalez-Villalpando, C., Lean, M. E., & Haffner, S. M. (2002). Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care, 25(11), 2016–2021.
dcterms.referencesHeiss, G., Snyder, M. L., Teng, Y., Schneiderman, N., Llabre, M. M., Cowie, C., … Gallo, L. (2014). Prevalence of metabolic syndrome among Hispanics/Latinos of diverse background: the Hispanic Community Health Study/Study of Latinos. Diabetes Care, 37(8), 2391-2399. doi:
dcterms.referencesIliff, D. (2001). Guidelines for diagnosis and treatment of high cholesterol. JAMA, 286(19), 2400-2401; author reply 2401-2402.
dcterms.referencesJiménez, A. E. R., Navarro, J., Islas, M. C., DFranchis, L. J. C., Gómez, J. L., Pichardo, C. N., … López, F. R. E. (2009). Prevalencia del síndrome metabólico en relación con las concentraciones de ácido úrico. Medicina Interna de México, 25(4),
dcterms.referencesJossa, F., Farinaro, E., Panico, S., Krogh, V., Celentano, E., Galasso, R., … Trevisan, M. (1994). Serum uric acid and hypertension: the Olivetti heart study. Journal of Human Hypertension, 8(9), 677-681.eng
dcterms.referencesKahn, R. (2003). Follow-up report on the diagnosis of diabetes mellitus: the expert committee on the diagnosis and classifications of diabetes mellitus. Diabetes Care, 26(11), 3160.
dcterms.referencesKang, D.-H., & Nakagawa, T. (2005). Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease. In Seminars in nephrology (Vol. 25, pp. 43-49).
dcterms.referencesLizarazu Díazgranados, I., Rossi Trespalacios, C., Iglesias Acosta, J., & Mendoza Torres, E. (2010). Síndrome metabólico en trabajadores de la Universidad Libre Seccional Barranquilla, 2009. Salud Uninorte, 26(1),
dcterms.referencesLópez-Jaramillo, P., Pradilla, L. P., Castillo, V. R., & Lahera, V. (2007). Patología socioeconómica como causa de las diferencias regionales en las prevalencias de síndrome metabólico e hipertensión inducida por el embarazo. Revista Española de Cardiología, 60(2), 168-178.
dcterms.referencesManzur, F., de la Ossa, M., Trespalacios, E., Abuabara, Y., & Lujan, M. (2008). Prevalencia de síndrome metabólico en el municipio de Arjona, Colombia. Revista Colombiana de Cardiología, 15(5),
dcterms.referencesMárquez-Sandoval, F., Bulló, M., Vizmanos, B., Casas-Agustench, P., & Salas-Salvadó, J. (2008). Un patrón de alimentación saludable: la dieta mediterránea tradicional. Antropo, 16,
dcterms.referencesMatesanz Ruiz, C., Caro de Miguel, C., Campos, F., Gómez de Terreros Caro, J., Ariñez Fernández, C., & Gutiérrez Ortega, C. (2006). Descripción del valor de la proteína C reactiva según dislipemia e historia de tabaquismo. Prevención Del Tabaquismo, 8(1),
dcterms.referencesMatía Martín, P., Lecumberri Pascual, E., & Calle Pascual, A. L. (2007). Nutrición y síndrome metabólico. Revista Española de Salud Pública, 81(5), 489-505.
dcterms.referencesMelnyk, O. O. (2017). Metabolic syndrome and the risk of chronic kidney disease. KIDNEYS, 6(2), 80-90.
dcterms.referencesMody, P., Joshi, P. H., Khera, A., Ayers, C. R., & Rohatgi, A. (2016). Beyond coronary calcification, family history, and C-Reactive protein: cholesterol efflux capacity and cardiovascular risk prediction. Journal of the American College of Cardiology, 67(21), 2480-2487.
dcterms.referencesPineda, C. A. (2008). Síndrome metabólico: definición, historia, criterios. Colombia Médica, 39(1), 96-106spa
dcterms.referencesPulido, D. I., Scott, M. L., Barreras, C., Soto, F., Barrios, C., & López, C. M. (2016). Síndrome de ovario poliquístico en mujeres portadoras de síndrome metabólico. Revista Médica Clínica Las Condes, 27(4), 540-544.
dcterms.referencesRidker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003). C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. Circulation, 107(3), 391-397.
dcterms.referencesRidker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002). Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New England Journal of Medicine, 347(20), 1557-1565.
dcterms.referencesRodríguez, R. G., & García, J. C. (2016). Hábitos de vida saludables en el síndrome metabólico. Medimay, 22(1),
dcterms.referencesRosales, L., Rivas, E. T., & Troconis, T. J. B. (2017). Estudio de la relación entre las características genéticas asociadas a la leptina y el síndrome metabólico. Caso de un grupo familiar con evidencias de trastorno. Acta Bioclínica, 7(14),
dcterms.referencesSakkinen, P. A., Wahl, P., Cushman, M., Lewis, M. R., & Tracy, R. P. (2000). Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. American Journal of Epidemiology, 152(10), 897-907.
dcterms.referencesSoca, P. E. M. (2009). El síndrome metabólico: un alto riesgo para individuos sedentarios. Acimed, 20(2),
dcterms.referencesSrikanthan, K., Feyh, A., Visweshwar, H., Shapiro, J. I., & Sodhi, K. (2016). Systematic review of metabolic syndrome biomarkers: a panel for early detection, management, and risk stratification in the West Virginian population. International Journal of Medical Sciences, 13(1), 25.
dcterms.referencesTesta, R., Vanhooren, V., Bonfigli, A. R., Boemi, M., Olivieri, F., Ceriello, A., … Bacalini, M. G. (2015). N-glycomic changes in serum proteins in type 2 diabetes mellitus correlate with complications and with metabolic syndrome parameters. PLoS One, 10(3), e0119983.
dcterms.referencesTovar, A. P., & Celemin, C. (2016). Menopausia y síndrome metabólico. RFS, 7(1), 69-76.
dcterms.referencesValenzuela, A. (2016). Ácido úrico:?` un nuevo factor contribuyente al desarrollo de obesidad? Revista Chilena de Nutrición, 43(3), 303-307.
dcterms.referencesVirtanen, M., Ferrie, J. E., Akbaraly, T., Tabak, A., Jokela, M., Ebmeier, K. P., … Kivimäki, M. (2017). Metabolic Syndrome and Symptom Resolution in Depression: A 5-Year Follow-Up of Older Adults. J Clin Psychiatry, 78(1), e1-e7.

Ficheros en el ítem


Este ítem aparece en la(s) siguiente(s) colección(ones)

  • Artículos
    Artículos científicos evaluados por pares

Mostrar el registro sencillo del ítem